Optigen Ingredients Pty Ltd v Alltech, Inc

Optigen Ingredients Pty Ltd (Optigen) and Alltech, Inc (Alltech) were parties to a dispute before the Federal Court of Australia. The core of the disagreement concerned the alleged infringement of Optigen's Australian Patent No 2009201777 (the Patent), which relates to a process for producing a specific type of yeast product. Optigen claimed that Alltech's activities in Australia, specifically the importation and sale of its "All-G Rich" yeast product, constituted an infringement of its patent rights. Alltech denied infringement and sought to have the patent invalidated.

The primary legal issues before the Court were whether Alltech's "All-G Rich" product was made by the patented process, and if so, whether this constituted infringement of Optigen's patent. Additionally, the Court was required to consider Alltech's defence that the patent was invalid, particularly on the grounds of lack of novelty and obviousness. The Court had to determine the scope of the patent claims and whether the evidence established that the "All-G Rich" product was manufactured using a process that fell within the claims of the Patent.

In its reasoning, the Court analysed the technical evidence presented by both parties regarding the manufacturing processes. It considered the specific steps and conditions described in Optigen's patent claims and compared them to the process used by Alltech to produce "All-G Rich". The Court applied the principles of patent law concerning infringement, focusing on whether the alleged infringing product was made by the patented process. The Court also examined the prior art and the inventive step requirement to assess the validity of the patent. Ultimately, the Court found that Alltech's "All-G Rich" product was not made by the process claimed in Optigen's patent, and therefore, there was no infringement. The Court also found that the patent was valid.